UAB Biotechnologijos grupė Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 2,022,624 |
| 130,408 |
| 171,601 |
| 145,858 |
| 9,404 |
| 36.63 |
| 7.21 |
| 331,334 |
| 366,987 |
| 336,383 |
| 412,151 |
| 2024 |
|---|
| 2,346,883 |
| 138,133 |
| 264,489 |
| 224,782 |
| 13,230 |
| 22.15 |
| 9.58 |
| 556,116 |
| 261,290 |
| 367,004 |
| 455,788 |
| 2025 |
|---|
| 2,684,747 |
| 146,707 |
| 305,329 |
| 270,504 |
| 14,782 |
| 47.96 |
| 10.08 |
| 826,620 |
| 530,265 |
| 487,018 |
| 952,050 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 2,684,747 |
| 146,707 |
| 305,329 |
| 270,504 |
| 14,782 |
| 47.96 |
| 10.08 |
| 826,620 |
| 530,265 |
| 487,018 |
| 952,050 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
2,684,747 €14 % *
Sales per employee (€)
146,707 €6 % *
Profit before tax (€)
305,329 €15 % *
Net Profit (€)
270,504 €20 % *
Profit per employee (€)
14,782 €12 % *
Total profitability (%)
47.96 %116.52 % *
Net profitability (%)
10.08 %5.22 % *
Equity (€)
826,620 €49 % *
Amounts Payable And Liabilities (€)
530,265 €103 % *
Non-current Assets (€)
487,018 €33 % *
CurrentAssets (€)
952,050 €109 % *
